Davide Campari-Milano Zukünftiges Wachstum

Future Kriterienprüfungen 3/6

Davide Campari-Milano wird ein jährliches Gewinn- und Umsatzwachstum von 15.7% bzw. 6% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 14% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 11.8% betragen.

Wichtige Informationen

15.7%

Wachstumsrate der Gewinne

14.0%

EPS-Wachstumsrate

Beverage Gewinnwachstum	11.3%
Wachstumsrate der Einnahmen	6.0%
Zukünftige Eigenkapitalrendite	11.8%
Analystenabdeckung	Good
Zuletzt aktualisiert	13 Nov 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Keine Aktualisierungen

Recent updates

With A 26% Price Drop For Davide Campari-Milano N.V. (BIT:CPR) You'll Still Get What You Pay For

Nov 17

It's Probably Less Likely That Davide Campari-Milano N.V.'s (BIT:CPR) CEO Will See A Huge Pay Rise This Year

Apr 05

Davide Campari-Milano N.V.'s (BIT:CPR) Popularity With Investors Is Clear

Mar 30

Investors Appear Satisfied With Davide Campari-Milano N.V.'s (BIT:CPR) Prospects

Dec 27

Returns At Davide Campari-Milano (BIT:CPR) Appear To Be Weighed Down

Dec 15

Does Davide Campari-Milano (BIT:CPR) Have A Healthy Balance Sheet?

Nov 19

Are Davide Campari-Milano N.V. (BIT:CPR) Investors Paying Above The Intrinsic Value?

Oct 22

Here's Why We Think Davide Campari-Milano (BIT:CPR) Is Well Worth Watching

Oct 10

Is Davide Campari-Milano (BIT:CPR) Using Too Much Debt?

Aug 12

Returns On Capital At Davide Campari-Milano (BIT:CPR) Have Stalled

Jul 29

Here's Why We Think Davide Campari-Milano (BIT:CPR) Is Well Worth Watching

Jun 29

These 4 Measures Indicate That Davide Campari-Milano (BIT:CPR) Is Using Debt Reasonably Well

May 05

Here's What To Make Of Davide Campari-Milano's (BIT:CPR) Decelerating Rates Of Return

Apr 22

Here's Why Davide Campari-Milano N.V.'s (BIT:CPR) CEO Might See A Pay Rise Soon

Apr 07

If EPS Growth Is Important To You, Davide Campari-Milano (BIT:CPR) Presents An Opportunity

Mar 23

Davide Campari-Milano (BIT:CPR) Shareholders Will Want The ROCE Trajectory To Continue

Jan 13

Should You Be Adding Davide Campari-Milano (BIT:CPR) To Your Watchlist Today?

Nov 18

Returns At Davide Campari-Milano (BIT:CPR) Are On The Way Up

Oct 15

Is Davide Campari-Milano (BIT:CPR) A Risky Investment?

Oct 02

Does Davide Campari-Milano (BIT:CPR) Deserve A Spot On Your Watchlist?

Aug 16

Are Davide Campari-Milano N.V. (BIT:CPR) Investors Paying Above The Intrinsic Value?

Jul 31

We Think Davide Campari-Milano (BIT:CPR) Can Manage Its Debt With Ease

Jun 22

There's Been No Shortage Of Growth Recently For Davide Campari-Milano's (BIT:CPR) Returns On Capital

Jun 07

Davide Campari-Milano (BIT:CPR) Has A Rock Solid Balance Sheet

Mar 17

Davide Campari-Milano (BIT:CPR) Has Some Way To Go To Become A Multi-Bagger

Feb 28

Gewinn- und Umsatzwachstumsprognosen

BIT:CPR - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (EUR Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	3,418	458	363	N/A	18
12/31/2025	3,219	394	206	N/A	19
12/31/2024	3,032	343	20	N/A	20
9/30/2024	2,994	308	N/A	N/A	N/A
6/30/2024	2,984	333	-34	415	N/A
3/31/2024	2,914	342	N/A	N/A	N/A
12/31/2023	2,919	331	-159	157	N/A
9/30/2023	2,922	512	N/A	N/A	N/A
6/30/2023	2,899	351	-45	214	N/A
3/31/2023	2,737	367	N/A	N/A	N/A
12/31/2022	2,698	333	25	380	N/A
9/30/2022	2,563	329	90	396	N/A
6/30/2022	2,429	324	155	412	N/A
3/31/2022	2,301	305	246	448	N/A
12/31/2021	2,173	285	338	484	N/A
9/30/2021	2,088	280	306	447	N/A
6/30/2021	2,004	275	274	410	N/A
3/31/2021	1,888	231	233	344	N/A
12/31/2020	1,772	188	193	278	N/A
9/30/2020	1,768	223	195	284	N/A
6/30/2020	1,763	259	197	291	N/A
3/31/2020	1,803	284	234	327	N/A
12/31/2019	1,843	308	271	363	N/A
9/30/2019	1,812	290	245	334	N/A
6/30/2019	1,782	272	218	304	N/A
3/31/2019	1,747	284	231	316	N/A
12/31/2018	1,712	296	245	328	N/A
9/30/2018	1,714	346	243	323	N/A
6/30/2018	1,715	395	N/A	319	N/A
3/31/2018	1,734	376	N/A	315	N/A
12/31/2017	1,753	356	N/A	311	N/A
9/30/2017	1,776	282	N/A	300	N/A
6/30/2017	1,799	208	N/A	289	N/A
3/31/2017	1,763	187	N/A	342	N/A
12/31/2016	1,727	166	N/A	395	N/A
9/30/2016	1,685	166	N/A	415	N/A
6/30/2016	1,643	165	N/A	435	N/A
3/31/2016	1,650	170	N/A	370	N/A
12/31/2015	1,657	175	N/A	305	N/A
9/30/2015	1,644	162	N/A	305	N/A
6/30/2015	1,632	150	N/A	304	N/A
3/31/2015	1,596	139	N/A	294	N/A
12/31/2014	1,560	129	N/A	283	N/A
9/30/2014	1,536	139	N/A	254	N/A
6/30/2014	1,512	150	N/A	226	N/A
3/31/2014	1,518	150	N/A	223	N/A
12/31/2013	1,524	150	N/A	221	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: CPRDas prognostizierte Gewinnwachstum (15.7% pro Jahr) liegt über der Sparquote (2.5%).

Ertrag vs. Markt: CPRDie Erträge des Unternehmens (15.7% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Italian (7.3% pro Jahr).

Hohe Wachstumserträge: CPRDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: CPRDie Einnahmen des Unternehmens (6% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Italian (4% pro Jahr).

Hohe Wachstumseinnahmen: CPRDie Einnahmen des Unternehmens (6% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: CPRDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (11.8%).

Davide Campari-Milano Zukünftiges Wachstum

Future Kriterienprüfungen 3/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

With A 26% Price Drop For Davide Campari-Milano N.V. (BIT:CPR) You'll Still Get What You Pay For

New minor risk - Profit margin trend

Non-Executive Chairman recently bought €19m worth of stock

Investor sentiment deteriorates as stock falls 18%

Now 28% undervalued after recent price drop

Davide Campari-Milano N.V. (BIT:CPR) announces an Equity Buyback for €40 million worth of its shares.

Calculating The Fair Value Of Davide Campari-Milano N.V. (BIT:CPR)

Davide Campari-Milano (BIT:CPR) Has A Somewhat Strained Balance Sheet

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 16%

Davide Campari-Milano N.V. (BIT:CPR) acquired 14.60% stake in Capevin Holdings Proprietary Limited for £69.6 million.

Second quarter 2024 earnings released: EPS: €0.062 (vs €0.074 in 2Q 2023)

Getting In Cheap On Davide Campari-Milano N.V. (BIT:CPR) Is Unlikely

Non-Executive Chairman recently sold €788k worth of stock

Davide Campari-Milano N.V. completed the acquisition of Courvoisier S.A.S. from Beam Suntory Inc for approximately €1.2 billion.

Upcoming dividend of €0.065 per share

It's Probably Less Likely That Davide Campari-Milano N.V.'s (BIT:CPR) CEO Will See A Huge Pay Rise This Year

Davide Campari-Milano N.V.'s (BIT:CPR) Popularity With Investors Is Clear

Dividend increased to €0.065

Davide Campari-Milano N.V. signed an agreement to acquire the 100% stake in Courvoisier S.A.S. from Beam Suntory Inc for approximately $1.30 billion.

Full year 2023 earnings: EPS misses analyst expectations

New minor risk - Shareholder dilution

Davide Campari-Milano N.V. announced that it has received €1.200000005 billion in funding

Davide Campari-Milano N.V. announced that it has received €1.200000005 billion in funding

Investors Appear Satisfied With Davide Campari-Milano N.V.'s (BIT:CPR) Prospects

Returns At Davide Campari-Milano (BIT:CPR) Appear To Be Weighed Down

Does Davide Campari-Milano (BIT:CPR) Have A Healthy Balance Sheet?

Executive MD exercised options and sold €926k worth of stock

Are Davide Campari-Milano N.V. (BIT:CPR) Investors Paying Above The Intrinsic Value?

Here's Why We Think Davide Campari-Milano (BIT:CPR) Is Well Worth Watching

Executive MD exercised options and sold €2.8m worth of stock

Is Davide Campari-Milano (BIT:CPR) Using Too Much Debt?

Davide Campari-Milano N.V. to Report First Half, 2024 Results on Jul 30, 2024

Returns On Capital At Davide Campari-Milano (BIT:CPR) Have Stalled

First half 2023 earnings released

Here's Why We Think Davide Campari-Milano (BIT:CPR) Is Well Worth Watching

Executive MD exercised options and sold €2.7m worth of stock

Executive MD exercised options and sold €82k worth of stock

Campari Pays Homage to Milano Through the Launch of the Iconic New Bottle Inspired by Its Home

These 4 Measures Indicate That Davide Campari-Milano (BIT:CPR) Is Using Debt Reasonably Well

Here's What To Make Of Davide Campari-Milano's (BIT:CPR) Decelerating Rates Of Return

Upcoming dividend of €0.06 per share at 0.5% yield

Here's Why Davide Campari-Milano N.V.'s (BIT:CPR) CEO Might See A Pay Rise Soon

If EPS Growth Is Important To You, Davide Campari-Milano (BIT:CPR) Presents An Opportunity

Executive MD recently sold €660k worth of stock

Executive MD exercised options and sold €470k worth of stock

Full year 2022 earnings: EPS misses analyst expectations

Davide Campari-Milano (BIT:CPR) Shareholders Will Want The ROCE Trajectory To Continue

Davide Campari-Milano N.V. to Report Q1, 2023 Results on May 02, 2023

Should You Be Adding Davide Campari-Milano (BIT:CPR) To Your Watchlist Today?

Less than half of directors are independent

Non-Executive Chairman recently bought €1.0m worth of stock

Davide Campari-Milano N.V. (BIT:CPR) agreed to acquire 70% stake in Wilderness Trail Distillery, LLC from Shane Baker and Pat Heist for approximately $420 million.

Davide Campari-Milano N.V. (BIT:CPR) acquired a minority stake in Catalyst Spirits Inc.

Returns At Davide Campari-Milano (BIT:CPR) Are On The Way Up

Is Davide Campari-Milano (BIT:CPR) A Risky Investment?

Espolòn(R) Tequila Unveils Cristalino: an Elevated and Crystal Clear Addition to Their Portfolio

Non-Executive Director recently bought €56k worth of stock

Non-Executive Director recently bought €99k worth of stock

Davide Campari-Milano N.V. (BIT:CPR) acquired 15% stake in Wooler Brands, Inc. from Catalyst Spirits for $115 million.

Does Davide Campari-Milano (BIT:CPR) Deserve A Spot On Your Watchlist?

Non-Executive Director recently bought €52k worth of stock

Non-Executive Chairman recently bought €5.2m worth of stock

Are Davide Campari-Milano N.V. (BIT:CPR) Investors Paying Above The Intrinsic Value?

Davide Campari-Milano N.V., Annual General Meeting, Apr 13, 2023

First half 2022 earnings released

Non-Executive Chairman recently bought €8.2m worth of stock

We Think Davide Campari-Milano (BIT:CPR) Can Manage Its Debt With Ease

There's Been No Shortage Of Growth Recently For Davide Campari-Milano's (BIT:CPR) Returns On Capital

Davide Campari-Milano N.V. (BIT:CPR) acquired Picon Brand and Related Assets of Diageo plc (LSE:DGE) for €120 million

Non-Executive Director recently bought €51k worth of stock

Less than half of directors are independent

Upcoming dividend of €0.06 per share

Non-Executive Chairman recently bought €1.9m worth of stock

Non-Executive Chairman recently bought €8.0m worth of stock